Survival rates unaffected by end-of-life discussions
Survival rates unaffected by end-of-life discussions
Results support initiating dialog
Discussing and documenting patients' preferences for care at the end of life does not cause them any harm, contrary to recent claims. A study1 published in the Journal of Hospital Medicine found that patients who talk with their physicians about end-of-life care and have an advance directive in their medical record have similar survival rates as patients who do not have these discussions and documents.
The study included 356 patients admitted at three hospitals who had low or medium risks of dying within one year. Patients were followed from 2003 to 2009. During the study, there were no differences in survival for patients who had end-of-life discussions and those who did not; there also were no survival differences for those who had a living will in their medical record and those who did not.
"Our findings are reassuring. They support healthcare providers, who can initiate these discussions, and policymakers, who seek to reimburse these time-consuming discussions," said lead researcher Stacy M. Fischer, MD, assistant professor, University of Colorado School of Medicine. "Most importantly, our findings are reassuring for patients and families who desire these discussions with their healthcare providers. The term 'death panels' has sparked considerable controversy recently. It has undermined the efforts of clinicians who provide end-of-life care by scaring patients into thinking that their lives may be cut short for their families' or society's best interest." Fischer hopes the study provides data to help inform the national debate about advance directives for key stakeholders, healthcare providers, policymakers, and patients and families.
Reference
- Fischer S, Min SJ, Sauaia A, et al. "They're going to unplug grandma": Advance directive discussions and documentation do not decrease survival in patients at baseline lower risk of death. J Hosp Med; published online Sept. 29 2011, Doi: 10.1002/jhm.930.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.